China Vacuum Blood Collection Industry Report, 2014-2017
  • Mar.2015
  • Hard Copy
  • USD $2,350
  • Pages:96
  • Single User License
    (PDF Unprintable)       
  • USD $2,200
  • Code: ZLC017
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,300
  • Hard Copy + Single User License
  • USD $2,550

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it into specimens prior to blood analysis.

As a key integral part of the vacuum blood collection system, vacuum blood collection tubes get chiefly used for collection and preservation of blood specimens. In 2009-2013, the consumption of vacuum blood collection tubes in China presented a CAGR of 22.1%, and the figure in 2014 was estimated to reach 4.702 billion pcs, with the per capita use of 3.44 pcs/a.

Given the huge potentials of Chinese vacuum blood collection market, foreign giants represented by BD, Terumo and Sekisui Chemical have set up sole proprietorships or joint ventures in China, and occupied the high-end market in the country. At present, foreign brands account for only about 30% of the sales volume, but share up to 60% of the revenue.

Amonglocal Chinese companies -- Improve Medical, Kehua Bio-engineering, Weigao, Rich Science Industry, Liuyang Medical Instrument Factory, Gongdong Medical, etc., Improve Medical is the leader with higher annual capacity, namely 500 million blood collection tubes and 200 million blood collection needles. In 2014, Improve Medical achieved the revenue of RMB232 million from vacuum blood collection system with the sales volume of 496 million pcs.

Lured by the promising vacuum blood collection industry, Yuyue Medical, China Sun Pharmaceutical Machinery and other medical device manufacturers have tapped into the industry.

In 2012, Yuyue Medical invested additional RMB80 million in Suzhou Yuyue Medical for the capacity construction of vacuum blood collection tubes and Air purifiers. In 2013, it embarked on the R & D of vacuum blood collection tubes. In October 2012, China Sun Pharmaceutical Machinery pledged to lavish RMB154.3 million in building 10 production lines of vacuum blood collection tubes and blood collection needles; upon completion, it will be capable of producing 400 million germ-free glass vacuum blood collection tubes, 400 million sterile plastic vacuum blood collection tubes and 800 million blood collection needles annually.

The report covers the following aspects:
20120114.gifOverview of the global vacuum blood collection industry, involving development course, status quo, etc;
20120114.gifOverview of China vacuum blood collection industry, embracing status quo, relevant policies, barriers to entry, competition pattern, import and export, etc.;
20120114.gifOperation and vacuum blood collection system business of 12 Chinese companies and three foreign peers;
20120114.gifForecast for China vacuum blood collection industry and operation comparison between main players.

真空采血管 英文_副本.png

1 Overview
1.1 Definition
1.2 Classification

2 Overview of Global Vacuum Blood Collection Industry
2.1 Development Course
2.2 Status Quo

3 Overview of China Vacuum Blood Collection Industry
3.1 Status Quo
3.2 Relevant Policies
3.3 Barriers to Entry
3.4 Competition Pattern 
3.5 Import and Export
3.5.1 Import
3.5.2 Export

4 Major Chinese Enterprises
4.1Guangzhou Improve Medical Instruments 
4.1.1 Profile 
4.1.2 Operation 
4.1.3 Revenue Structure 
4.1.4 Gross Margin 
4.1.5 Vacuum Blood Collection System Business 
4.1.6 R & D 
4.1.7 Anticipation and Prospect 
4.2 Shanghai Kehua Bio-Engineering
4.2.1 Profile 
4.2.2 Operation 
4.2.3 Revenue Structure 
4.2.4 Gross Margin 
4.2.5 Vacuum Blood Collection System Business 
4.2.6 R & D 
4.2.7 Anticipation and Prospect 
4.3 Shandong Weigao Group Medical Polymer
4.3.1 Profile 
4.3.2 Operation 
4.3.3 Revenue Structure 
4.3.4 Gross Margin 
4.3.5 Vacuum Blood Collection System Business 
4.3.6 R & D 
4.3.7 Customers 
4.3.8 Anticipation and Prospect 
4.4 Chengdu Rich Science Industry  
4.4.1 Profile 
4.4.2 Operation 
4.4.3 Revenue Structure 
4.4.4 Gross Margin 
4.4.5 R & D 
4.4.6 Vacuum Blood Collection System Business 
4.4.7 Marketing and Procurement 
4.4.8 Anticipation and Prospect 
4.5 HunanLiuyang Medical Instrument Factory
4.5.1 Profile 
4.5.2 Vacuum Blood Collection System Business 
4.6 Sekisui Medical Technology (China) Co., Ltd.
4.6.1 Profile 
4.6.2 Vacuum Blood Collection System Business 
4.7 Shanghai Kindly Enterprise Development Group
4.7.1 Profile 
4.7.2 Vacuum Blood Collection System Business 
4.8 WeihaiHongyu Medical Devices 
4.8.1 Profile 
4.8.2 Vacuum Blood Collection System Business 
4.9 HunanChina Sun Pharmaceutical Machinery
4.9.1 Profile 
4.9.2 Operation 
4.9.3 Revenue Structure 
4.9.4 Gross Margin 
4.9.5 Vacuum Blood Collection System Business 
4.9.6 R & D 
4.9.7 Anticipation and Prospect 
4.10 Jiangsu Yuyue Medical Equipment & Supply
4.10.1 Profile 
4.10.2 Operation 
4.10.3 Revenue Structure 
4.10.4 Gross Margin 
4.10.5 R & D 
4.10.6 Vacuum Blood Collection System Business 
4.10.7 Anticipation and Prospect 
4.11 Other Enterprises
4.11.1TianjinHanaco Medical  
4.11.2Zhejiang Gongdong Medical Technology

5 Major Foreign Enterprises
5.1 BD(Becton, Dickinson and Company)
5.1.1 Profile 
5.1.2 Operation 
5.1.3 Revenue Structure 
5.1.4 Gross Margin 
5.1.5 Development in China
5.1.6 Vacuum Blood Collection System Business 
5.2 Terumo 
5.2.1 Profile 
5.2.2 Operation 
5.2.3 Revenue Structure 
5.2.4 R & D 
5.2.5 Development in China
5.2.6 Vacuum Blood Collection System
5.3 Nipro
5.3.1 Profile 
5.3.2 Operation 
5.3.3 Revenue Structure 
5.3.4 Vacuum Blood Collection System Business 
5.3.5 Development in China

6 Prediction and Outlook
6.1 Forecast for China Vacuum Blood Collection Industry
6.1.1 Growth of Medical and Health Care Costs
6.1.2 Increase of Patient Number
6.1.3 Raised per Capita Income  
6.1.4 Population Growth, Aging of Population
6.1.5 Further Improved Medical Insurance System
6.2 Operation Comparison between Main Enterprises
6.2.1 Revenue 
6.2.2 Net Income 
6.2.3 Gross Margin 
6.2.4 Vacuum Blood Collection System Business 
Classification and Applications of Vacuum Blood Collection Tubes
Classification of Vacuum Blood Collection Tubes (by Cranial Color)
Development Characteristics of Vacuum Blood Collection System by Generation
Performance of Vacuum Blood Collection System by Generation
Consumption of Vacuum Blood Collection Tube in the World, 2005-2014
Consumption of Vacuum Blood Collection Tube in China, 2009-2014
Gap between Chinese and Foreign Enterprises in Vacuum Blood Collection Tube
Policies aboutChina Medical Device Industry, 2007-2014
China's Vacuum Blood Collection System Market Pattern
Sales Volume Structure of China Vacuum Blood Collection Industry (by Region), 2014
Revenue Structure of China Vacuum Blood Collection Industry (by Region), 2014
Capacity of Major Enterprises in China Vacuum Blood Collection Industry, 2014
Layout of Major Enterprises in China Vacuum Blood Collection Industry
Import Volume and Value of Other Needles, Catheters, Cannulas and Similar Supplies in China, 2012-2014
Top 10 Import Sources of Other Needles, Catheters, Cannulas and Similar Supplies in China by Import Volume, 2014
Export Volume and Value of Other Needles, Catheters, Cannulas and Similar Supplies in China, 2012-2014
Top 10 Export Destinations of Other Needles, Catheters, Cannulas and Similar Supplies in China by Export Volume, 2014
Revenue and Net Income of Improve Medical, 2010-2014
Revenue of Improve Medical (by Product), 2010-2014
Revenue Structure of Improve Medical (by Product), 2010-2014
Revenue of Improve Medical (by Region), 2010-2014
Revenue Structure of Improve Medical (by Region), 2010-2014
Gross Margin of Improve Medical, 2010-2014
Gross Margin of Improve Medical (by Product), 2010-2014
Gross Margin of Improve Medical (by Region), 2010-2014
Revenue and YoY Growth Rate of Vacuum Blood Collection System of Improve Medical, 2010-2014
R & D Costs and YoY Growth Rate of Improve Medical, 2011-2014
New Products of Improve Medical and Its Subsidiaries, 2014
Production and Marketing of Improve Medical, 2013-2014
Revenue and Net Income of Improve Medical, 2013-2017E
Product Structure of Kehua Bio-engineering  
Revenue and Net Income of Kehua Bio-engineering, 2010-2014
Revenue of Kehua Bio-engineering (by Product), 2010-2014
Revenue Structure of Kehua Bio-engineering (by Product), 2010-2014
Revenue of Kehua Bio-engineering (by Region), 2010-2014
Revenue Structure of Kehua Bio-engineering (by Region), 2010-2014
Gross Margin of Kehua Bio-engineering, 2010-2014
Gross Margin of Kehua Bio-engineering (by Product), 2010-2014
Gross Margin of Kehua Bio-engineering (by Region), 2010-2014
Revenue and YoY Growth Rate of Vacuum Blood Collection System of Kehua Bio-engineering, 2011-2014
R & D Costs and YoY Growth Rate of Kehua Bio-engineering, 2011-2014
New Products, Patents and CE Certifications of Kehua Bio-engineering, 2006-2014
Revenue and Net Income of Kehua Bio-engineering, 2013-2017E
Wego’s Product Categories and Main Products
Wego's Revenue and Net Income, 2010-2014
Wego's Revenue (by Product), 2010-2014
Wego's Revenue Structure (by Product), 2010-2014
Revenue of Wego's Disposable Medical Supplies (by Product), 2012-2013
Wego's Revenue and YoY Growth Rate (by Region), 2013H1 vs 2014H1
Wego's Revenue Structure (by Region), 2014H1
Wego's Gross Margin, 2010-2014
Revenue and YoY Growth Rate of Wego's Blood Collection Products, 2010-2013
Wego's Patents and Registration Certificates, 2007-2013
Wego's R & D Costs and YoY Growth Rate, 2010-2014
Wego's Number of Customers (by Group), 2008-2014
Wego's Revenue and Net Income, 2012-2017E
Revenue and Net Income of Rich Science Industry, 2012-2014
Revenue of Rich Science Industry (by Product), 2012-2014
Revenue Structure of Rich Science Industry (by Product), 2012-2014
Revenue of Rich Science Industry (by Region), 2012-2014
Revenue Structure of Rich Science Industry (by Region), 2012-2014
Gross Margin of Rich Science Industry, 2012-2014
Gross Margin of Rich Science Industry (by Product), 2012-2014
Gross Margin of Rich Science Industry (by Region), 2012-2014
R & D Costs and % of Total Revenue of Rich Science Industry, 2012-2013
Vacuum Blood Collection System Revenue and % of Total Revenue of Rich Science Industry, 2012-2014
Top 5 Customers of Rich Science Industry by Revenue, 2012-2013
Top 5 Suppliers s of Rich Science Industry by Procurement, 2012-2013
Revenue and Net Income of Rich Science Industry, 2012-2017E
Blood Collection Needle Classification and Composition of KDL
Revenue and Net Income of China Sun Pharmaceutical Machinery, 2010-2014
Revenue of China Sun Pharmaceutical Machinery (by Product), 2010-2014
Revenue Structure of China Sun Pharmaceutical Machinery (by Product), 2010-2014
Revenue of China Sun Pharmaceutical Machinery (by Region), 2010-2014
Revenue Structure of China Sun Pharmaceutical Machinery (by Region), 2010-2014
Gross Margin of China Sun Pharmaceutical Machinery, 2010-2014
Gross Margin of China Sun Pharmaceutical Machinery (by Product), 2010-2014
Gross Margin of China Sun Pharmaceutical Machinery (by Region), 2012-2014
R & D Costs and YoY Growth Rate of China Sun Pharmaceutical Machinery, 2010-2013
Revenue and Net Income of China Sun Pharmaceutical Machinery, 2013-2017E
Revenue and Net Income of Yuyue Medical, 2010-2014
Revenue of Yuyue Medical (by Product), 2010-2014
Revenue Structure of Yuyue Medical (by Product), 2010-2014
Revenue of Yuyue Medical (by Region), 2010-2014
Revenue Structure of Yuyue Medical (by Region), 2010-2014
Gross Margin of Yuyue Medical, 2010-2014
Gross Margin of Yuyue Medical (by Product), 2010-2014
Gross Margin of Yuyue Medical (by Region), 2010-2014
R & D Costs and YoY Growth Rate of Yuyue Medical, 2010-2014
Revenue and Net Income of Yuyue Medical, 2012-2017E
BD's Revenue and Net Income, FY2010-FY2015
BD's Revenue (by Business), FY2010-FY2014
BD's Revenue Structure (by Business), FY2010-FY2014
BD's Revenue (by Region), FY2010-FY2014
BD's Revenue Structure (by Region), FY2010-FY2014
BD's Gross Margin, FY2010-FY2014
BD's Vacuum Blood Collection System Revenue and YoY Growth Rate, FY2010-FY2014
Terumo's Revenue and Net Income, FY2010-FY2014
Terumo's Revenue (by Division), FY2010-FY2013
Terumo's Revenue Structure (by Division), FY2010-FY2013
Terumo's Revenue (by Region), FY2010-FY2013
Terumo's Revenue Structure (by Region), FY2010-FY2013
Terumo's R & D Costs and YoY Growth Rate, FY2010-FY2013
Terumo's Subsidiaries in China and Main Business
Terumo's Layout in China
Revenue and YoY Growth Rate of Terumo's Blood Management Division, FY2010-FY2013 
Nipro's Revenue and Net Income, FY2010-FY2014
Nipro's Revenue (by Region), FY2011-FY2014
Nipro's Revenue Structure (by Region), FY2011-FY2014
Nipro's Revenue (by Division), FY2011-FY2014
Nipro's Revenue Structure (by Division), FY2011-FY2014
Revenue and YoY Growth Rate of Nipro's Medical-related Divisions, FY2011-FY2014
Nipro's Major Subsidiaries in China and Business
China's Vacuum Blood Collection Tube Consumption, 2013-2017E
China's Total Health Expenditure and YoY Growth Rate, 2009-2013
China's Per Capita Health Expenditure and YoY Growth Rate, 2009-2013
China's Number of Patients and YoY Growth Rate, 2010-2014
Urban and Rural Per Capita Income in China, 2010-2014
China's Total Population and YoY Growth Rate, 2010-2014
China's Population Aged over 65 and% of Total Population, 2010-2014
Population Covered by Medical Insurance and Expenditure in China
Revenue of Major Enterprises in China Vacuum Blood Collection Industry, 2010-2014
Net Income of Major Enterprises in China Vacuum Blood Collection Industry, 2010-2014
Gross Margin of Major Enterprises in China Vacuum Blood Collection Industry, 2010-2014
Vacuum Blood Collection System Revenue of Major Enterprises in China Vacuum Blood Collection Industry, 2010-2014

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

Global and China Industrial Enzyme Industry Report, 2014-2017

In recent years, the global industrial enzyme preparation market size increased year by year, registering a CAGR of 5%, approximating USD4.2178 billion in 2014. At present, the global industrial enzym...

China Blood Product Industry Report, 2015-2018

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Human Vaccine Industry Report, 2015-2018

A vaccine is a preventive biological product for human use that prevents and controls the occurrence and prevalence of infectious diseases, so the demand for such products is relatively rigid. Due to ...

China Vacuum Blood Collection Industry Report, 2014-2017

The vacuum blood collection system consisting of vacuum blood collection tubes, disposable blood collection needles, tourniquets, etc transfers human venous blood to closed containers and makes it int...

China Pharmaceutical Excipients Industry Report, 2014-2017

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are als...

China Recombinant Protein Drug Industry Report, 2014-2017

The Chinese recombinant protein drug market has been expanding rapidly owing to the improvement of demand rigidity, consumption ability and the like. During 2005-2013, sales of recombinant protein dru...

China Heparin Industry Report, 2014-2017

As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China’s heparin products. In 2013, the live pigs rais...

Global and China Monoclonal Antibody Industry Report, 2014-2019

Despite world-wide economic downturn and great changes in exchange rate, benefiting from robust market demand, global monoclonal antibody market size exceeded USD 80 billion in 2013, still one of biot...

Global and China DNA Sequencing Industry Research Report, 2014-2017

DNA sequencing is the process of reading nucleotide bases in a specific DNA molecule, that is to say determining the arrangement mode of adenine, thymine, cytosine, and guanine. It can be applied in a...

Global and China Stem Cell Industry Report, 2014-2017

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatmen...

China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlie...

China Blood Product Industry Report, 2014-2017

Plasma resource reserves and control are crucial to the development of blood products industry. Although the closure of 16 plasma collection stations in Guizhou in 2011 didn’t cause major disruption t...

China Animal Vaccine Industry Report, 2013-2016

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. Europe and the United States and other developed countries are the main ...

China Contract Research Organization (CRO) Industry Report, 2013-2016

China CRO industry has developed rapidly in recent years, registering a CAGR of 27.2% during 2007-2013, of which the market size reached RMB 36 billion in 2013, occupying 10% of global market share. ...

Global and China Biodegradable Plastics Industry Report, 2013-2016

Global biodegradable plastic production and demand have grown rapidly in recent years, and the capacity reached 1-1.5 million t/a in 2012-2013. Among dozens of biodegradable plastic varieties develope...

Global and China Industrial Enzyme Industry Report, 2014-2016

In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small...

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe’s total) and heparin APIs are gradual...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号